Table:
begin	end	state
1	35	cytoplasmic
36	56	transmembrane
57	68	non-cytoplasmic
69	111	transmembrane
112	116	non-cytoplasmic
117	140	transmembrane
141	146	cytoplasmic
147	164	transmembrane
165	184	non-cytoplasmic
185	207	transmembrane
208	235	cytoplasmic
236	260	transmembrane
261	266	non-cytoplasmic
267	285	transmembrane
286	290	cytoplasmic
291	310	transmembrane
311	316	non-cytoplasmic
317	335	transmembrane
336	340	cytoplasmic

Input:
>WP_011601464.1 NCBI__GCF_000058485.1:WP_011601464.1
MSTTDTAATSEATRVTGRDSAGPTKRSGRIIPRLGLDRFSGLYVLAALIIAYGIWLPDTF
LTSQTARSVADGQAIAAIVALALVVPLAAGVFDLSVAATLGFSVCLVAWLQGHHVNAILS
VLTAVAAGIVIGAVNSLVIIVLRVNSFIGTLGMGSLLAAGSYWITDGQTLIKGFSPDLLK
AGRAQPAGIPVTVWYLVGIALVLWFVLEYTPVGRYFYAVGANPQASRLAGLRVDRLVARS
LILAGFLSALGGAILAAKLGLGSPDVGPPYLLPAFSAAFLGATQIKSGRVNVLGTLVAVY
LLGVGVKGLQLAGAPSYVGDLFNGAALIIAVALAARTSRK

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server